For purposes of this brochure, unless otherwise noted, the “Advisers” mean (i) Bain Capital Private Equity, LP (“Bain Capital Private Equity”), a Delaware limited partnership, (ii) Bain Capital Double Impact, LP (“Bain Capital Double Impact”), a Delaware limited partnership, (iii) Bain Capital Life Sciences, LP (“Bain Capital Life Sciences”), a Delaware limited partnership, and (iv) Bain Capital Tech Opportunities, LP (“Bain Capital Tech Opportunities”), a Delaware limited partnership, each of which are wholly owned by Bain Capital, LP (“Bain Capital”). Bain Capital Private Equity provides investment advisory services to pooled investment vehicles (the “Bain Capital Private Equity Funds”)1 that are exempt from registration under the Investment Company Act of 1940, as amended (the “1940 Act”), and whose securities are not registered under the Securities Act of 1933, as amended (the “Securities Act”). Bain Capital Double Impact provides investment advisory services to pooled investment vehicles (the “Bain Capital Double Impact Funds”) that are exempt from registration under the 1940 Act and whose securities are not registered under the Securities Act. Bain Capital Life Sciences provides investment advisory services to pooled investment vehicles (the “Bain Capital Life Sciences Funds”) that are exempt from registration under the 1940 Act and whose securities are not registered under the Securities Act. Bain Capital Tech Opportunities provides investment advisory services to a pooled investment vehicle (the “Bain Capital Tech Opportunities Fund”) 2 that is exempt from registration under the 1940 Act and whose securities are not registered under the Securities Act. As the investment advisers of the Bain Capital Private Equity Funds, the Bain Capital Double Impact Funds, the Bain Capital Life Sciences Funds, the Bain Capital Tech Opportunities Funds (collectively, the “Funds”), the applicable Adviser, along with each Fund’s General Partner (each a “General Partner” or “GP”, and collectively the “General Partners”), identifies investment opportunities for, and participates in the acquisition, management, monitoring and disposition of investments of, each applicable Fund. Each Adviser operates its business as follows: (1) Bain Capital Private Equity. The primary focus of Bain Capital Private Equity’s investment advisory activity is researching and advising on private equity investments, including leveraged acquisitions and recapitalizations, investments in growth companies, turnarounds and traditional buyouts in a wide variety of industries. Such investments take the form of privately negotiated investment instruments including unregistered equity from both U.S. and non-U.S. issuers. Although the primary focus of each Bain Capital Private Equity Fund is on private equity investments, Bain Capital Private Equity may from time to time recommend other types of investments consistent with the respective Bain Capital Private Equity Fund’s investment strategy and objectives. (2) Bain Capital Double Impact. The primary focus of Bain Capital Double Impact’s investment advisory activity is researching and advising on investments in self- 1 Where applicable, includes wholly owned subsidiaries and Alternative Investment Vehicles (AIVs) related to transactions with Bain Capital Private Equity Funds. 2 Where applicable, includes wholly owned subsidiaries and AIVs related to transactions with Bain Capital Double Impact Funds, Bain Capital

Life Sciences Funds, and Bain Capital Tech Opportunities Funds, respectively. identified impact- or mission-oriented companies and more traditional businesses with positive impact products and services. These include control investments in lower middle market growth equity companies and minority and other investment structures. Such investments may take the form of privately negotiated investment instruments including unregistered equity and debt instruments from both U.S. and non-U.S. issuers consistent with each Bain Capital Double Impact Fund’s investment strategy and objectives. Although the primary focus of Bain Capital Double Impact Funds is on controlling equity investments, Bain Capital Double Impact may from time to time recommend other types of investments consistent with the respective Bain Capital Double Impact Fund’s investment strategy and objectives. (3) Bain Capital Life Sciences. The primary focus of Bain Capital Life Sciences’ investment advisory activity is researching and advising on investments primarily in biopharmaceutical, medical device, diagnostics and enabling life science technology companies. These include companies that need capital to achieve the next milestone, accelerate or expand growth or re-establish momentum following a setback. Although the primary focus of Bain Capital Life Sciences Funds is on controlling equity investments, Bain Capital Life Sciences also recommends other types of investments consistent with the respective Bain Capital Life Sciences Fund’s investment strategy and objectives, including investments in public companies. (4) Bain Capital Tech Opportunities. The primary focus of Bain Capital Tech Opportunities’ investment advisory activity is researching and advising on investments in technology and technology-enabled companies. These include a mix of majority, control positions of the securities of a portfolio company and minority and other investment structures. Although the primary focus of Bain Capital Tech Opportunities is pursuing investments based in North America, it may also selectively pursue investments in other geographic regions. The Advisers provide investment advisory services to the applicable Funds pursuant to separate investment and advisory agreements (each, an “Advisory Agreement”). Investment advice is provided by an Adviser directly to the applicable Funds, subject to the direction and control of the affiliated General Partner of such Fund and not individually to the investors in the Funds. Any restrictions on investments in certain types of securities are established by the General Partner of the applicable Fund and are set forth in the documentation received by each limited partner prior to investment in such Fund. Once invested in a Fund, investors cannot impose restrictions on the types of securities in which such Fund may invest. Currently there are no restrictions on the types of securities in which a Fund may invest. Bain Capital Private Equity has been in business since 1984. As of December 31, 2022, Bain Capital Private Equity, Bain Capital Double Impact, Bain Capital Life Sciences, and Bain Capital Tech Opportunities collectively managed approximately $78,603,075,0003 of client assets, all of which are managed on a discretionary basis. 3 Bain Capital Private Equity does not have ultimate investment discretion with respect to the assets of any Bain Capital Private Equity Fund, as such discretion is retained by the applicable General Partner of each Bain Capital